CRC Research Update — July 10, 2026
Today's colorectal cancer research highlights
stage-iii
A collection of 25 issues
Stage III/IV MSI-H CRC Shows Reduced T-Cell Infiltration and Elevated IDO1
Skip to content
The CRC Digest
Stage III/IV MSI-H CRC Shows Reduced T-Cell Infiltration and Elevated IDO1
Analysis of 217 patients with dMMR/MSI-H colorectal cancer found that stage III/IV tumors had reduced immune infiltration and upregulated epithelial IDO1 expression compared to stage I/II, suggesting immune evasion
CRC Research Update — July 02, 2026
Today's colorectal cancer research highlights
CRC Research Finding
Skip to content
The CRC Digest
▪ Personalized ctDNA Test Detects Stage III Recurrence Before Imaging
A case series of four stage III CRC patients showed the Signatera ctDNA assay detected recurrence earlier than imaging and informed curative interventions. (Cancer Diagnosis & Prognosis)
This content is informational only and does not
CRC Research Update — June 27, 2026
Today's colorectal cancer research highlights
One-year surveillance colonoscopy after curative resection evaluated for diagnostic yield
Skip to content
The CRC Digest
One-year surveillance colonoscopy after curative resection evaluated for diagnostic yield
A retrospective study examined real-world outcomes of routine colonoscopy 1 year after colorectal cancer resection, despite limited evidence supporting its diagnostic yield. (Int J Colorectal Dis)
This content is informational only and does not
CRC Research Update — June 22, 2026
Today's colorectal cancer research highlights
CRC Research Update — June 10, 2026
Today's colorectal cancer research highlights
CRC Research Update — June 04, 2026
Today's colorectal cancer research highlights
CRC Research Update — June 01, 2026
Today's colorectal cancer research highlights